Press release
Coronary Stents Market to Expand at a CAGR of of 6.6% Between 2016 and 2026
Future Market Insights provides an in-depth analysis of the global coronary stents market in a new report titled “Coronary Stents Market: Global Industry Analysis and Opportunity Assessment, 2016-2026”. Coronary stents is a billion dollars industry that occupies a significant market share in the cardiovascular market. In terms of revenue, the global coronary stents market is estimated to reach a market valuation of US$ 6,002.9 Mn by 2016 end and is expected to register a CAGR of 6.6% during the forecast period. The global coronary stents market is expected to represent incremental opportunity of US$ 5,318.7 Mn between 2016 and 2026.According to Future Market Insights, factors such as an increase in the prevalence of coronary artery disease, obesity, and minimal invasive procedures; and an increasing preference for advanced stenting procedures by cardiologists are some of the factors fuelling the growth of the global coronary stents market. Economic factors such as an increase in awareness campaigns about cardiovascular diseases conducted by government bodies, rapid progress in medical technology, and extended reimbursement support are also expected to boost the growth of the global coronary stents market over the forecast period.
Request For Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1993
Segmentation highlights
The global coronary stents market is segmented on the basis of Product Type (Drug Eluting Stent, Bare Metal Stent, Bioresorbable Vascular Stent); Raw Material (Cobalt Chromium, Stainless Steel, Platinum-Chromium, Nickel-Titanium, Polymer); and End Use (Hospitals, Ambulatory Surgical Centres, Cardiac Catheterisation Laboratories).
The Drug Eluting Stent product type segment is estimated to be valued at US$ 8,750.2 Mn by 2026. The Bioresorbable Vascular Stent segment is estimated to account for 11.0% revenue share by 2016 end
The Polymer raw material segment is estimated to account for the highest market share of 29.2% by the end of 2016. The Cobalt Chromium segment is expected to register a CAGR of 5.6% during the forecast period
The Hospitals end use segment is anticipated to account for 70.9% value share of the global coronary stents market by the end of 2016. The Cardiac Catheterisation Laboratories segment is estimated to be valued at US$ 2,526.8 Mn by the end of 2026, registering a CAGR of 8.0% over the forecast period
Regional projections
The global coronary stents market is segmented on the basis of region into North America, Latin America, Western Europe, Eastern Europe, APEJ, MEA, and Japan. The APEJ market is estimated to be valued at US$ 4,165.2 Mn by 2026, exhibiting a CAGR of 8% during the forecast period. The North America coronary stents market is expected to dominate the global coronary stents market in terms of revenue by 2016 end and is likely to retain its dominance throughout the forecast period. The coronary stents market in North America is estimated to account for 29.2% market share of the global coronary stents market by 2016 end. The North America region is likely to be the second most attractive market with an attractiveness index of 2.5 during the forecast period. The markets in North America, Western Europe, and APEJ represent the highest growth opportunities in the global coronary stents market owing to a large patient population and an increasing demand for coronary stents in these regions.
Send An Enquiry@ http://www.futuremarketinsights.com/askus/rep-gb-1993
Vendor insights
The global coronary stents market report profiles some of the top companies operating in the market. Leading market players featured in the report include Terumo Corporation, Boston Scientific Corporation, Medtronic, Vascular Concepts, B. Braun Melsungen AG, Biotronik SE & Co. KG, Abbott Laboratories, Biosensors International Group, Ltd., Hexacath, and Stentys SA. Key market players are focussing on increasing their footprints in emerging markets such as Asia Pacific and are expanding their manufacturing facilities and distribution network to gain a larger share of the global coronary stents market.
ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.
CONTACT:
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Press@futuremarketinsights.com
Website: www.futuremarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Coronary Stents Market to Expand at a CAGR of of 6.6% Between 2016 and 2026 here
News-ID: 407057 • Views: …
More Releases from Future Market Insights

Maca Magic Unleashed: Black Maca Extract Market Set to Hit USD 119.1 million by …
The Quiet Revolution of Natural Wellness: Market Trajectory
The global market for Black Maca Extract is experiencing a powerful, yet consistent, surge driven by the modern consumer's pivot toward natural and proactive health management. Far from a passing fad, this market is demonstrating robust and stable growth, with projections showing its value will nearly double over the next decade. Based on recent analysis, the market is set to expand from an…

Fluoroquinolones ELISA Kit Market to Reach USD 144.7 Million by 2035 with 8.5% C …
The global fluoroquinolones ELISA kit market is set to undergo a decade of steady and transformative growth, rising from an estimated USD 64 million in 2025 to a projected USD 144.7 million by 2035. This expansion, at a compound annual growth rate (CAGR) of 8.5%, reflects the increasing need for accurate, reliable, and efficient diagnostic tools across industries such as food safety, pharmaceuticals, veterinary care, and environmental monitoring.
From 2021 to…

Medical Implants Precision Machining Service Market Poised for 6.4% CAGR Growth …
Global Market Outlook: A Decade of Expanding Precision
The medical implants precision machining service market is entering a decisive decade, with a strong growth trajectory driven by demand for advanced surgical solutions and innovations in multi-axis machining technologies. According to new projections, the market will expand from USD 1,056.4 million in 2025 to USD 1,964.5 million by 2035, marking a compound annual growth rate (CAGR) of 6.4%.
Between 2021 and 2025, the…

NGS Solution for Early Cancer Screening Market to Reach USD 2,393.5 million by 2 …
Early Cancer Detection Enters a Transformative Era
The fight against cancer is undergoing a profound transformation as the global healthcare sector accelerates the adoption of next-generation sequencing (NGS) technologies for early cancer detection. According to market forecasts, the NGS solution for early cancer screening market will grow from USD 591.6 million in 2025 to nearly USD 2,393.5 million by 2035, representing a 305% total growth and a 15% compound annual growth…
More Releases for Stent
Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage
An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period.
The future outlook for the airway stent lung…
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion.
Market Revenue Growth
The global airway stent/lung stent market is on an…
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the…
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire…
Global Evar Stent Grafts Market, Global Evar Stent Grafts Industry, Covid-19 Imp …
The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some of…
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients…